Henkel to Acquire Olaplex

Henkel to Acquire Olaplex at $2.06 a share, creating a 55% premium that frames arbitrage and shareholder positioning ahead of an H2 2026 close.

March 26, 2026·2 min read
View all news articles
Henkel to Acquire Olaplex cover showing a flat-vector shampoo bottle merging into a hair-care emblem on a cobalt gradient

KEY TAKEAWAYS

  • Henkel will pay $2.06 per share in cash, valuing Olaplex at about $1.4 billion.
  • Deal represents a 55% premium to the March 25, 2026 close and 45% to 30-day VWAP.
  • Olaplex board and majority holder approvals remove the need for a stockholder vote; close expected in H2 2026.

HIGH POTENTIAL TRADES SENT DIRECTLY TO YOUR INBOX

Add your email to receive our free daily newsletter. No spam, unsubscribe anytime.

Or subscribe with

Henkel AG & Co. KGaA said in a press release on March 26, 2026, that it will acquire Olaplex Holdings, Inc. (OLPX) under a definitive cash agreement approved by Olaplex’s board and majority shareholder. The deal, expected to close in the second half of 2026, will expand Henkel’s premium hair-care portfolio.

Deal Terms and Approvals

Henkel will pay $2.06 per share in cash, valuing Olaplex at about $1.4 billion. This represents a 55% premium to Olaplex’s closing price on March 25, 2026, and a 45% premium to its 30-day volume-weighted average price ending that date. The merger agreement was unanimously approved by Olaplex’s board, and Advent International, which controls roughly 75% of Olaplex’s voting power, provided written consent, eliminating the need for a stockholder vote.

The transaction requires antitrust and regulatory approvals, including review under the Hart-Scott-Rodino Act in the U.S. and clearances in Germany, Australia, and the U.K. The agreement sets an outside date of March 31, 2027, extendable to September 30, 2027. It also includes a $40.44 million termination fee payable by Olaplex under specified conditions.

After closing, Olaplex will become a wholly owned subsidiary of Henkel and will be delisted from Nasdaq. The companies said the deal combines Olaplex’s premium brand with Henkel’s global reach and resources to accelerate innovation and international growth. Olaplex reported about €370 million in sales for fiscal 2025 and had previously guided for fiscal 2026 revenue ranging from a 2% decline to a 3% increase.

Henkel CEO Carsten Knobel said, "This transaction allows us to expand our presence in premium hair care."

HIGH POTENTIAL TRADES SENT DIRECTLY TO YOUR INBOX

Add your email to receive our free daily newsletter. No spam, unsubscribe anytime.

Or subscribe with

Read other top news stories

Netflix Earnings Send NFLX Stock Lower

Netflix Earnings Send NFLX Stock Lower

Netflix earnings for Q1 2026 beat forecasts but weak Q2 guidance and Reed Hastings' planned June exit pushed shares lower in after-hours trading.

Anthropic Mythos Rolls Out to Banks Amid Cyber Scrutiny

Anthropic Mythos Rolls Out to Banks Amid Cyber Scrutiny

Anthropic Mythos limited Glasswing rollout to banks prompted regulator scrutiny and raised cyber and operational risk, complicating bank positioning.

Spirit Airlines Liquidation Looms as Fuel Costs Surge

Spirit Airlines Liquidation Looms as Fuel Costs Surge

Spirit Airlines liquidation risk rises as jet fuel may exceed year-end cash, prompting creditors' doubts and forcing traders to reassess credit exposure.

AMD Stock Rises on Bernstein Raise and AI Demand

AMD Stock Rises on Bernstein Raise and AI Demand

AMD stock rose after Bernstein raised its 12-month target as record EPYC and MI300 data-center demand boosted flows ahead of May 5 Q1 2026 earnings.

Anthropic Claude Opus 4.7 Launches to General Availability

Anthropic Claude Opus 4.7 Launches to General Availability

Anthropic Claude Opus 4.7 went general; pricing stayed unchanged and Mythos stayed gated, a setup that could shift cloud AI costs and investor positioning.

Abbott Earnings Beat After Exact Sciences Deal

Abbott Earnings Beat After Exact Sciences Deal

Abbott earnings posted revenue and adjusted-profit beats but narrowed FY EPS guidance after the Exact Sciences acquisition, likely pressuring shares.